Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings
Movement Disorders · 2023
DOI: 10.1002/mds.29308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2023. Verfasst von Yuanyuan Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Tremor, Parkinson Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Background
Regulatory recommendations favor outcomes combining objective and patient input. The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS), the most commonly used scale in Parkinson's disease (PD), includes patient and investigator ratings in distinct parts, but original clinimetric analyses failed to confirm the validity of combining parts by simple summing.
Objectives
The aim was to develop clinimetrically valid constructs for combining patient‐reported Part 2 and investigator‐rated Part 3 MDS‐UPDRS scores.
Methods
Using 7888 MDS‐UPDRS scores, we assessed construct validity of combined Part 2 and Part 3 items using exploratory factor analysis (EFA) and graded item response theory (IRT) with threshold criteria: comparative fit index ≥0.9 (EFA) and discrimination parameters ≥0.65 (IRT).
Results
The direct sum of Parts 2 + 3 failed to meet the threshold for a valid outcome of PD severity (comparative fit index, CFI = 0.855). However, a two‐domain construct combining item scores for tremor and non‐tremor domains from Parts 2 and 3 confirmed validity, meeting both EFA and IRT criteria as distinct but correlated indices of disease severity (CFI = 0.923; discrimination mean 2.197 ± 0.480 [tremor] and 1.737 ± 0.344 [non‐tremor] domains).
Conclusions
The sum of Parts 2 + 3 is not clinimetrically sound. However, considering tremor and non‐tremor items of both Parts 2 and 3 as two outcomes results in a valid summary of PD motor severity that leverages simultaneous patient‐ and investigator‐derived measures. This analytic application addresses regulatory prioritizations and retains the well‐validated MDS‐UPDRS items. In future interventional trials, we suggest that tremor and non‐tremor components of PD motor severity from Parts 2 + 3 be monitored and analyzed to accurately detect objective changes that integrate the patient's voice. © 2023 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina, USA.
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
- Division of Neurology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Christopher G Goetz, Tiago A Mestre, Sheng Luo
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Guo, Y., Goetz, C. G., Stebbins, G. T., Mestre, T. A., & Luo, S. (2023). Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings. Movement Disorders. https://doi.org/10.1002/mds.29308
Vancouver
Guo Y, Goetz CG, Stebbins GT, Mestre TA, Luo S. Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings. Movement Disorders. 2023. doi:10.1002/mds.29308
BibTeX
@article{Guo2023,
author = {Guo, Yuanyuan and Goetz, Christopher G and Stebbins, Glenn T and Mestre, Tiago A and Luo, Sheng},
title = {Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings},
journal = {Movement Disorders},
year = {2023},
doi = {10.1002/mds.29308}
}
EUVIMED